Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hemorrhage 6Leiomyoma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seizures 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasms 2Menorrhagia 2Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Thrombocytopenia 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Seroma 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Postoperative Complications 1Pneumonia 1Patient Satisfaction 1Pain 1Osteosarcoma 1

Interventions

maleimide-polyethylene glycol-modified hemoglobin, MP4 1Tranexamic Acid 1Sodium Chloride 1Saline Solution 1Ringer's Solution 1Ringer's Lactate 1Misoprostol 1Embolization, Therapeutic 1Cerebral Angiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Blood Loss, Surgical × Tranexamic Acid × Clear all
NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

University Hospital, Linkoeping

Phase 4 Completed
100 enrolled 11 charts
Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡